Roche Diagnostics cobas™ Liat SARS-CoV-2, Influenza A/B and RSV Control Kit

The cobas™ liat SARS-CoV-2, Influenza A/B and RSV control kit for use with the cobas liat SARS-CoV-2, Influenza A/B and RSV assay. Control kit includes three positive and three negative controls.

The cobas™ liat SARS-CoV-2, Influenza A/B and RSV control kit for use with the cobas liat SARS-CoV-2, Influenza A/B and RSV assay. Control kit includes three positive and three negative controls.

Content And Storage

20 Tests/Kit; Store at 2°C to 8°C

Control Sets

integrated sample processing control, positive and negative controls

CPT Code

87637

CE Marker

Yes

Clia Complexity

Waived (EUA)

Detectable Analytes

SARS-CoV-2, Influenza A and B, Rubella Virus Antibodies

Detection Method

Nucleic Acid RT-PCR

DoA Calibrators

No

Format

Kit

Sample Type

Nasaopharyngeal or anterior nasal

Sensitivity

Influenza A, B, RSV = 100% positive agreement; SARS-CoV-2=96.7% positive agreement

Type

Test

Disposable

Single-use

For Use With (Application)

Detection of SARS-CoV-2, Influenza A/B, and RSV

For Use With (Equipment)

Used with the cobas™ liat analyzer

Product Line

cobas™

Quantity

1

Specificity

SARS-CoV-2=96.7% negative agreement; Influenza A = 98.1% negative agreement; Influenza B = 97.7% negative agreement; RSV = 97.2% negative agreement

Test Time

20 min.

Analysis Time

20 min.

Dimensions (L x W x H)

10.6 x 6.5 x 5.4 in.

Weight (English)

2.4 lb.

Form

Ready-to-Use (RTU)